We see things a little different
We see that
…the “hidden chemistry” of nature, and in particular of food, is a treasure trove for new products that improve health, wellness and nutrition.
…with innovative biosynthetic technologies we can unlock this wealth for the benefit of individuals across the globe. And do so in a sustainable manner.
…the ability to creatively combine many new things, and to evolve and adapt, is an important capability, not only of our science, but of us as an organisation.
Welcome to Evolva
Reinach, Switzerland, 5 March 2014 - Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) announces that Credit Suisse, who is acting as Sole Bookrunner in the private placement announced on 25 February 2014, has exercised in full the over-allotment option of 4,050,000 shares at the placement price of CHF 1.37 per share.